February 1, 2008 - NightHawk Radiology will be a radiology provider for the High-Risk Plaque Initiative (HRP Initiative), a joint research effort to advance the understanding and management of high-risk plaque, which is believed to be the primary underlying cause of heart attacks and strokes.
February 1, 2008 - Medical Ventures Corp. signed an agreement to acquire two vascular product development companies ...
January 30, 2008 - Aporo Biomedical signed an exclusive global licensing agreement with mNEMOSCIENCE GmbH for its proprietary biodegradable shape memory polymers (BIO-SMP), enabling Aporo to offer devices with biodegradable closure features for treating structural heart diseases such as PFO and ASD.
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
January 30, 2008 - NightHawk Radiology is the exclusive radiology provider for the High-Risk Plaque Initiative, called ...
January 30, 2008 - Iroko Pharmaceuticals (Iroko) acquired all non-U.S. commercial rights to Aggrastat (tirofiban HCl) from Merck & Co. Inc., used for patients undergoing coronary angioplasty or atherectomy to prevent cardiac ischemic complications, in a move Iroko hopes will strengthen its presence in the cardiovascular market.
January 30, 2008 - TopSpin Medical Inc. installed the Cathamaran Intravascular MRI System at ZOL Hospital in Belgium, marking the first installation of the system and its entrance in a study on vulnerable plaque.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
January 30, 2008 - Cardica Inc.’s C-Port Distal Anastomosis Systems will be used in two courses to train cardiothoracic ...
January 30, 2008 - TopSpin Medical Inc. announced the first commercial installation of the Cathamaran Intravascular MRI System at ZOL Hospital, Genk, Belgium, with the first procedures performed on Jan. 16.
January 30, 2008 - Cardiac Science Corp. won two contracts to supply Powerheart automated external defibrillators (AEDs) ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
January 29, 2008 - The Medicines Company received the European Commission�s authorization of an expanded use for ...
Janssen-Cilag International NV announced IONSYS (fentanyl iontophoretic transdermal system), a new needle-free system ...
January 29, 2008 � A novel treatment for blood clots in the legs, in which injecting or �lacing� the clot with a ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
January 29, 2008 - Edwards Lifesciences Corp. received conditional approval from the FDA for the addition of the ...
Power Medical Interventions Inc. said the FDA cleared its 510(k) application for marketing its intelligent iDrive ...
January 28, 2008 - A new multi-center, international clinical trial that compares the safety and effectiveness of thoracic endovascular aortic repair (TEVAR) to open surgery for descending thoracic aortic aneurysms (TAA), indicates that TEVAR (the less invasive endovascular graft) is a promising treatment option for many patients.
January 31, 2008
